Searched for
SUPRIYA LIFESCIENCE STOCK NEWS
Stocks in news: Lenskart, GNG Electronics, Vedanta, Infosys, RILMarkets closed lower on weekly expiry day amid weak global cues, with selling pressure on every rise. Block deals in GNG Electronics and Le...- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...
- Stocks in news: Lenskart, PFC, RIL, Hindustan Zinc, Tata ConsumerIndian markets saw volatile trading on Wednesday, closing slightly down. Lenskart, PFC, RIL, Hindustan Zinc, and Tata Consumer are in focus...
- Zydus Lifesciences among 4 stocks that hit 52-week highs & rallied up to 17% in a monthThe Sensex ended marginally higher, while four BSE 200 stocks touched fresh 52-week highs, signaling strong investor confidence. Zydus Life...
- Zydus Lifesciences, 2 other share buybacks closing today. Are you participating?Investors have a final opportunity to tender shares in buyback offers from Zydus Lifesciences, Dhanuka Agritech, and CyberTech Systems and ...
- Stocks to buy in 2026 for long term: Bharti Airtel, IndiGo among 5 stocks that could give 10-30% return
- Kospi selloff resumes, tanks nearly 4% as AI unwinding continues; Iran war uncertainty dents moodSouth Korean stocks fell sharply on Wednesday, with the benchmark KOSPI dropping up to 3.6%, as semiconductor shares resumed their decline ...
- Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...
- Stocks in news: Bharti Airtel, Vodafone Idea, NLC India, Motilal Oswal, HCL TechIndian markets saw a sharp decline on Monday amid global worries and geopolitical tensions. Nifty moved closer to a key support level. Seve...
- US stocks: S&P 500, Nasdaq end up as tech, chipmakers reboundU.S. stocks largely rose Monday, with the Nasdaq and chipmakers leading the gains as investors sought bargains after Friday's selloff. Reli...
- One of UK's oldest listed cos Tate & Lyle accepts $3.6 billion bid from IngredionIngredion is set to acquire Tate & Lyle for 2.7 billion pounds, approximately 3.6 billion dollars. This deal marks the end of Tate & Lyle's...
- Chhagan Bhujbal takes jab at NCP leadership after Rajya Sabha snubThe Nationalist Congress Party (NCP) has nominated Rajendra Jain for a Rajya Sabha seat. This decision has disappointed senior leader Chhag...
- Congress cold, others in Opposition warm to CJP protest at Jantar MantarA protest called by the Cockroach Janta Party at Jantar Mantar has exposed deep divisions within the Opposition. While parties like AAP, SP...
- Ipca Laboratories among 5 stocks showing bullish RSI upswingFive Nifty500 stocks, including Leela Palaces, Eris Lifesciences, Indian Bank, Mankind Pharma, and Ipca Laboratories, showed bullish moment...
- 'Politics, family ties separate', says BJP candidate Arun Lakhani as son gets set to marry Supriya Sule's daughterIndustrialist Arun Lakhani, Bharatiya Janata Party's candidate for the Chandrapur-Wardha-Gadchiroli seat, asserts politics and family ties ...
- Supriya Sahu IAS is fascinated by this rare Nilgris plant: Even in harsh summer, its unique leaves can trap and store water to surviveIAS officer Supriya Sahu has brought attention to Hedyotis verticillaris, a rare plant found in the high-altitude grasslands of the Nilgiri...
- Supriya Lifescience shares surge 17% on strong Q4 earnings; PAT rises 47% YoYSupriya Lifescience shares jumped over 16% after the company posted a strong Q4FY26 performance, with PAT rising 47% YoY and revenue surgin...
- Zydus Lifesciences hikes share buyback price to Rs 1,260 per share, lowers share countZydus Lifesciences increased its share buyback price to Rs 1,260 per share while reducing the repurchase size to 87.3 lakh shares. The tota...
- Zydus Lifesciences buyback alert! Last date to buy shares to participate in Rs 1,100 crore buyback at 7% premiumInvestors must purchase Zydus Lifesciences shares by Wednesday, May 27, to be eligible for the Rs 1,100 crore buyback, as the record date i...
- Stock Radar: Zydus Lifesciences stock breaks out from inverse head & shoulder pattern to hit fresh 52-week high; time to buy?Zydus Lifesciences Ltd. broke out from an inverse head & shoulder pattern, hitting fresh 52-week highs and suggesting continued momentum. E...
Load More
